Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

INDIV 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Osteosarcoma 2Water Intoxication 1Psoriasis 1Ototoxicity 1Neoplasm, Residual 1Myasthenia Gravis 1Leukemia 1Inflammatory Bowel Diseases 1Hematologic Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Dementia 1Central Nervous System Neoplasms 1Breast Neoplasms 1Breast Cancer Organoids 1Alzheimer Disease 1Acute Kidney Injury 1

Interventions

ravulizumab 3Tacrolimus 3Pyridostigmine Bromide 3Prednisone 3Mycophenolic Acid 3Data Collection 3Azathioprine 3efgartigimod alfa 2Steroids 2Diagnostic Self Evaluation 2Blood Specimen Collection 2rozanolixizumab 1Thymectomy 1Therapeutics 1Telemedicine 1Neurofeedback 1Methylprednisolone 1Methotrexate 1Immunosuppressive Agents 1Immunoglobulins, Intravenous 1Genotype 1Cyclosporine 1Cyclophosphamide 1Biomarkers 1Alleles 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Myasthenia Gravis × Methotrexate × Clear all
NCT04101578 2021-08-23

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Da, Yuwei, M.D.

Unknown
2,000 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡